Post authored by David Moher All participants in research are important. What patients in clinical trials tell us about treatments – patient-reported outcomes (PROs) such as quality of life and symptoms – is being used
Emphasizing the fact that clinical trials can influence treatment decisions, the recent AllTrials campaign has called for all trials past and present to be registered, and the results reported. As one of the initiating organisations
As of today, PLOS is retiring its two “Hubs”, which have respectively highlighted and brought together open-access content in two specific areas: Biodiversity and Clinical Trials. These sites were initially developed to experiment with how
Last week BMJ published an article proposing a new initiative aimed at solving an age-old problem in medical publishing: that of the perennial failure of investigators and sponsors to publish all of the results of
The following post is by the Senior Editor of PLoS Medicine, Emma Veitch, and is a re-post of the “What is PLoS Medicine’s policy on trials registration?” article written for the Speaking of Medicine blog.